HLA-G is upregulated in advanced endometriosis
Carregando...
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2019
Editora
ELSEVIER SCIENCE BV
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, v.235, p.36-41, 2019
Resumo
Objective: To assess whether the HLA-G immunomodulatory protein is potentially involved in the pathophysiology of endometriosis or disease progression. Study design: Cross-sectional observational study of 227 women who underwent laparoscopy, being 146 for endometriosis excision and 81 for elective tubal ligation (control group). Soluble HLA-G (sHLA-G) levels in the serum and peritoneal fluid (PF), as well as the HLA-G protein expression in matched eutopic and ectopic endometrium of women with and without endometriosis were evaluated by ELISA and immunohistochemistry assays, respectively. Women with endometriosis were separated into groups according to the initial (I/II, n=60) and advanced (III/IV, n=86) stages of disease. sHLA-G measurement was performed only in women with matched serum and PF samples in both the control (CTRL; n=77) and endometriosis (EDT; I-II, n=60; n=83) groups. HLA-G protein expression was evaluated in 26 women with deep endometriosis (I-II, n=12; III-IV, n=14) and 22 controls. Results: Higher concentrations of sHLA-G (P=0.013) in the serum but not in the PF were observed in women with advanced endometriosis compared to the control group. In situ expression of HLA-G protein was also higher in ectopic (P=0.018) but not in eutopic endometrium of women with advanced endometriosis compared to control group. Conclusion: Our findings suggest that HLA-G upregulation in advanced stages may contribute to the state of immunosuppression in endometriosis as disease progresses.
Palavras-chave
Endometriosis, HLA-G antigens, Immunosuppression, Immunomodulation
Referências
- Abrao MS, 2006, FERTIL STERIL, V86, P543, DOI 10.1016/j.fertnstert.2006.02.102
- Agaugue S, 2011, BLOOD, V117, P7021, DOI 10.1182/blood-2010-07-294389
- Antsiferova YS, 2005, FERTIL STERIL, V84, P1705, DOI 10.1016/j.fertnstert.2005.05.066
- Barrier BF, 2006, HUM REPROD, V21, P864, DOI 10.1093/humrep/dei408
- Barrier BF, 2006, GYNECOL ONCOL, V103, P25, DOI 10.1016/j.ygyno.2006.01.045
- Borrelli GM, 2016, MOL HUM REPROD, V22, P329, DOI 10.1093/molehr/gaw009
- BRAUN DP, 1992, FERTIL STERIL, V57, P1203
- Canis M, 1997, FERTIL STERIL, V67, P817
- Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015
- Eidukaite A, 2008, FERTIL STERIL, V89, P465, DOI 10.1016/j.fertnstert.2007.02.036
- HALME J, 1984, OBSTET GYNECOL, V64, P151
- Ibrahim EC, 2000, CELL STRESS CHAPERON, V5, P207, DOI 10.1379/1466-1268(2000)005<0207:HSAAIE>2.0.CO;2
- KANZAKI H, 1992, AM J OBSTET GYNECOL, V167, P257, DOI 10.1016/S0002-9378(11)91670-6
- Kawashima M, 2009, FERTIL STERIL, V91, P343, DOI 10.1016/j.fertnstert.2007.12.005
- Leyendecker G, 2002, HUM REPROD, V17, P2725, DOI 10.1093/humrep/17.10.2725
- Leyendecker G, 2009, ARCH GYNECOL OBSTET, V280, P529, DOI 10.1007/s00404-009-1191-0
- Mach P, 2010, AM J REPROD IMMUNOL, V63, P387, DOI 10.1111/j.1600-0897.2009.00806.x
- Maeda Nagamasa, 2012, Front Biosci (Schol Ed), V4, P1568
- Malutan AM, 2015, CENT EUR J IMMUNOL, V40, P96, DOI 10.5114/ceji.2015.50840
- Malutan AM, 2015, J RES MED SCI, V20, P668, DOI 10.4103/1735-1995.166215
- Matarese G, 2003, TRENDS MOL MED, V9, P223, DOI 10.1016/S1471-4914(03)00051-0
- Menier C, 2003, HUM IMMUNOL, V64, P315, DOI 10.1016/S0198-8859(02)00821-2
- Monsanto SP, 2016, FERTIL STERIL, V105, P968, DOI 10.1016/j.fertnstert.2015.11.047
- Morandi F, 2007, CANCER RES, V67, P6433, DOI 10.1158/0008-5472.CAN-06-4588
- Moreau P, 1999, INT IMMUNOL, V11, P803, DOI 10.1093/intimm/11.5.803
- OOSTERLYNCK DJ, 1991, FERTIL STERIL, V56, P45
- OOSTERLYNCK DJ, 1992, FERTIL STERIL, V58, P290
- OOSTERLYNCK DJ, 1993, OBSTET GYNECOL, V82, P206
- OOSTERLYNCK DJ, 1994, AM J REPROD IMMUNOL, V31, P25, DOI 10.1111/j.1600-0897.1994.tb00843.x
- Osuga Y, 2011, AM J REPROD IMMUNOL, V65, P1, DOI 10.1111/j.1600-0897.2010.00887.x
- Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516
- Podgaec S, 2012, AM J REPROD IMMUNOL, V68, P301, DOI 10.1111/j.1600-0897.2012.01173.x
- Puppo Francesco, 2002, ScientificWorldJournal, V2, P421
- Rebmann V, 2003, HUM IMMUNOL, V64, P1017, DOI 10.1016/j.humimm.2003.08.354
- Rouas-Freiss N, 2007, SEMIN CANCER BIOL, V17, P413, DOI 10.1016/j.semcancer.2007.07.003
- Rutten MJ, 2014, J IMMUNOL RES, DOI 10.1155/2014/274584
- Sampson JA, 1927, AM J PATHOL, V3, P93
- Sebti Y, 2007, BRIT J HAEMATOL, V138, P202, DOI 10.1111/j.1365-2141.2007.06647.x
- Suen JL, 2014, AM J PATHOL, V184, P464, DOI 10.1016/j.ajpath.2013.10.023
- Tabibzadeh S, 2003, FRONT BIOSCI-LANDMRK, V8, pA70, DOI 10.2741/1045
- Wang F, 2008, FERTIL STERIL, V90, P1599, DOI 10.1016/j.fertnstert.2007.06.073
- Yang YP, 1996, J IMMUNOL, V156, P4224
Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/19
Artigos e Materiais de Revistas Científicas - LIM/58
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InCor
Artigos e Materiais de Revistas Científicas - LIM/19
Artigos e Materiais de Revistas Científicas - LIM/58